ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

ACS Funds $54 Million in Grants

June 28, 2002

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009